Alto Neuroscience, Inc. · NYSE:ANRO

K2 HealthVentures Equity Trust LLC's stake in Alto Neuroscience, Inc. fell to 2.40% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

K2 HealthVentures Equity Trust LLC's stake in Alto Neuroscience, Inc. fell to 2.40%, 788,995 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
2.40%
Shares
788,995
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
K2 HealthVentures Equity Trust LLC2.40%788,995
Parag Shah2.40%788,995
Anup Arora2.40%788,995

Source

View original at SEC

Related